A dated range for the medicine alone
On September 26, 2026, Novo Nordisk’s self-pay semaglutide prices spanned $149 to $499 per month across products and prescribed strengths. That range describes the medicine, not a complete care program.
Self-pay means paying through a cash route rather than having an insurer pay the claim. The lowest and highest amounts are not prices for a basic program and a premium program. They sit across different products and strengths. A price check needs the actual product planned by the person writing the prescription.
The manufacturer’s published cash prices checked on that date put semaglutide (Wegovy tablets) at $149 to $299 per monthly supply, depending on prescribed strength.
The bar on this page shows that tablet price spread. It is a price picture, not a treatment ladder. Nothing about its position tells a reader which product or strength fits their care. Keep that decision with the person writing the prescription and use the price information to ask a more precise billing question.
The opening price can have a limit
The injection offer recorded in September 2026 charged eligible new patients paying without using insurance $199 per month for their first two monthly fills. Only specified starting strengths qualified. The offer required patients to be U.S. residents aged 18 or older. Its published offer window ended December 31, 2026.
After those introductory fills, the manufacturer’s September 2026 cash prices for semaglutide (Ozempic injection) were $349 or $499 a month, depending on prescribed strength.
Eligibility and the prescribed strength both need checking. Ask the pharmacy to confirm that the proposed prescription meets the offer’s new-patient and starting-strength terms before budgeting around the opening price.
Ask for the cost after the introductory terms, using the same product name. Ask whether the quoted amount applies to the medicine alone. An opening offer is easier to assess when the later terms are written beside it rather than left for a later search.
A list price answers a different question
The September 2026 check of the maker’s pages found a list price of about $1,349 per package for semaglutide (Wegovy). The Ozempic page supported only an approximate list figure of $1,000 because it displayed conflicting amounts.
That inconsistency is a reason to avoid false precision. A list figure is useful for naming the price category. It is not a personal quote and cannot settle the cash or insurance bill. Ask the pharmacy or insurer for the amount that applies to the planned prescription.
Take a product-specific question forward
Write down the full medicine name and form. Ask whether the quoted supply is the same one being discussed with the person writing the prescription. Record whether the amount is a manufacturer cash offer, an insurance estimate or another kind of price.
Several offers recorded in September 2026 carried terms ending December 31, 2026. An end date calls for a fresh check; it does not establish what the replacement terms will be.
The figures here are a dated record, not a promise of a price available now. Request fresh written terms before planning around them. Ask for the drug bill and any separate service bill together, then return to the total-cost page to compare the complete offer.